GR Semicolon EN

Show simple item record

dc.contributor.author
Siokou, Anna
en
dc.date.accessioned
2018-06-06T11:02:44Z
dc.date.available
2018-06-07T00:00:17Z
dc.date.issued
2018-06-06
dc.identifier.uri
https://repository.ihu.edu.gr//xmlui/handle/11544/29207
dc.rights
Default License
dc.subject
Pharmaceuticals
en
dc.title
Parallel trade in pharmaceuticals
en
heal.type
masterThesis
en_US
heal.generalDescription
Parallel trade in pharmaceuticals
el
heal.keywordURI.LCSH
Commerce
heal.keywordURI.LCSH
Pharmaceutical industry
heal.keywordURI.LCSH
Pharmaceutical industry--Law and legislation
heal.keywordURI.LCSH
Pharmaceutical industry--Law and legislation--European Union countries
heal.keywordURI.LCSH
Pharmaceutical industry--Government policy
heal.keywordURI.LCSH
Pharmaceutical policy
heal.contributorName
Siokou, Anna
en
heal.language
en
en_US
heal.access
free
en_US
heal.license
http://creativecommons.org/licenses/by-nc/4.0
en_US
heal.recordProvider
School of Economics, Business Administration and Legal Studies, LLM in Transnational and European Commercial Law, Mediation, Arbitration and Energy Law
en_US
heal.publicationDate
2018-05-25
heal.abstract
This dissertation w as written as part of the LLM in Transnational and European Commercial Law, Mediation, Arbitration and Energy Law at the In ternational Hellenic University. In this dissertation, there will be analyzed the phenomenon of parallel trade in pharmaceuticals , which is based on the principle of parallel trade in pharmaceuticals, according to Articles 34, 35 and 36 TFEU, as mentioned in the first chapter. Moreover in the second chapter, there will be an analysis for the pharmaceutical market and the parallel trade in pharmaceutical sector. In the same chapter, there will be mentioned which is the importance of intellectual property r ights in pharmaceutical industry and, also, which is the meaning of Exhaustion of Intellectual Property Rights. The subsequent chapter refers to Articles 101 and 102 TFEU and the restraints in parallel trade of pharmaceutical products, which is an issue ex amined in many ECJ law - cases, some of which are mentioned to the fourth chapter. Finally, the last chapter has to do with positive and negative aspects of parallel trade in pharmaceuticals.
en
heal.advisorName
Dr. Papadopoulos, Thomas
el
heal.committeeMemberName
Dr. Papadopoulos, Thomas
en
heal.academicPublisher
IHU
en
heal.academicPublisherID
ihu
en_US


This item appears in the following Collection(s)

Show simple item record

Related Items